Table 3. Dominant TCR sequences identified by massively parallel sequencing after stimulation with WT or mutant peptides.
Vβ | CDR3 | Jβ | CDR3 length (amino acids) | Total no. of sequences | No. of unique sequences | ||
---|---|---|---|---|---|---|---|
SCL-42 WT-stimulated TCRs | |||||||
Vβ7 | LCASS | PNELGQGSAF | FGQGT | Jβ1.1 | 10* | 160 | 1 |
Vβ12 | FCASS | DEVNTEAF | FGQGT | Jβ1.1 | 8* | 18 | 1 |
Vβ24 | LCATS | TGTVMNTEAF | FGQGT | Jβ1.1 | 10 | 1332 | 6 |
SCL-42 mutant-stimulated TCRs | |||||||
Vβ7 | LCASS | ESWTDYGYT | FGSGT | Jβ1.2 | 9* | 97 | 1 |
Vβ12 | FCASS | DGGTRHEQF | FGPGT | Jβ2.1 | 9* | 160 | 2 |
Vβ24 | LCATS | RDTVNQPQH | FGDGT | Jβ1.5 | 9* | 2066 | 17 |
Corresponds to the expected length based on TCR spectratyping.